22 New Featured FDA 483s | August 9, 2016

Here are the featured FDA 483s for the week. You can obtain these at the FDAzilla 483s store here>>

Inspection End Date Company City/Local State/Region Country
9/17/2015 American Dent-all Inc Glendale CA United States
9/10/2015 Bedfont Scientific, Ltd. Maidstone United Kingdom
9/17/2015 Biomatlante Vigneux De Bretagne France
11/13/2015 Boehringer Ingelheim Pharma Gmbh & Co Kg Biberach An Der Ris Germany
11/9/2015 DDC Technologies Inc Oceanside NY United States
10/23/2015 Farmabios, S.p.A. Gropello Cairoli Italy
10/24/2014 Fresenius Kabi USA, LLC Grand Island NY United States
12/3/2015 G S Cosmeceutical USA Inc Livermore CA United States
3/17/2015 Gland Pharma Limited Ranga Reddy, Hyderabad India
12/9/2015 Invacare Corporation Elyria OH United States
9/18/2015 IVD Research, Inc. Carlsbad CA United States
9/5/2014 Larson, Richard A., M.D. Chicago IL United States
7/1/2011 Merck Serono S.p.A. Guidonia Montecelio Italy
11/12/2013 Merck Serono SA Aubonne Aubonne Switzerland
6/16/2011 Merck Serono SA Aubonne Aubonne Switzerland
12/4/2015 Myriad Genetics Laboratories, Inc. Salt Lake City UT United States
11/6/2015 Novo Nordisk A/S Kalundborg Denmark
9/11/2015 Oculo-Plastik, Inc. Montreal Canada
7/22/2015 Pacira Pharmaceuticals, Inc. San Diego CA United States
1/15/2016 Respironics California Inc Carlsbad CA United States
8/10/2015 Sanofi Pasteur Limited – Cannaught Campus North York Canada
1/29/2016 Teva Pharmaceutical Works Co. Ltd. Godollo Hungary

Learn more about how FDAzilla can help you achieve your quality and inspection preparation goals: get 483sInspector ProfilesEnforcement Analytics, and GMP Regulatory Intelligence. Contact me if you ever have questions at tony@fdazilla.com.

Like this post? Don't forget to share it!

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Recent Posts

Experience the Power of FDAzilla

Get your FREE account to search sites, inspections, & warning letters